Form 4: LeMaitre Vascular Director Acquires Dividend Equivalent Rights
SEC Form 4
Director Joseph P. Pellegrino JR. acquired dividend equivalent rights related to restricted stock unit awards and performance share units.
Summary
- On March 27, 2025, Joseph P. Pellegrino JR., a director of LeMaitre Vascular Inc. (LMAT), acquired dividend equivalent rights.
- These rights are associated with previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
- The acquisitions include 0.8293 rights related to a 2020 RSU award, 1.5788 rights related to a 2021 RSU award, 3.2147 rights related to a 2022 RSU award, 3.2147 rights related to a 2022 PSU award, 4.1217 rights related to a 2023 RSU award, 4.9389 rights related to a 2023 PSU award, and 3.9776 rights related to a 2024 RSU award.
- Each dividend equivalent right is the economic equivalent of one share of LeMaitre Vascular's common stock and vests proportionately with the underlying award.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing. It simply reports a transaction and doesn't inherently indicate positive or negative sentiment about the company's prospects.
Positives
- The acquisition of dividend equivalent rights by a director signals continued alignment with shareholder interests.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and is typical for publicly traded companies like LeMaitre Vascular. It provides transparency regarding the holdings and transactions of company insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders.
- Similar filings are common among LeMaitre Vascular's competitors in the medical device industry, such as Medtronic, Boston Scientific, and Abbott Laboratories, when their executives or directors trade company stock or related derivatives.
Stakeholder Impact
- The acquisition of dividend equivalent rights by a director could be viewed positively by shareholders as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 12/02/2020 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/11/2021 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/12/2022 | Date of restricted stock unit and performance share unit award grants related to dividend equivalent rights. |
| 12/08/2023 | Date of restricted stock unit and performance share unit award grants related to dividend equivalent rights. |
| 12/06/2024 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 03/27/2025 | Date of transaction: Acquisition of dividend equivalent rights. |
| 03/31/2025 | Date of Form 4 signature. |
Keywords
dividend equivalent rights, Form 4, insider trading, LMAT, LeMaitre Vascular, director, Joseph P. Pellegrino JR., RSU, PSU
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.